Pfizer cuts full-year outlook due to declining sales of Covid-19-related products
New York: Shares of Pfizer are in retreat on the first day of trading after the drug company said sales ...
Read moreDetailsNew York: Shares of Pfizer are in retreat on the first day of trading after the drug company said sales ...
Read moreDetailsNew Delhi: Vulnerable people aged 65 years and over receiving the Pfizer bivalent mRNA vaccine booster dose showed 72 per ...
Read moreDetailsLos Angeles: The US Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) have ...
Read moreDetailsNew York: Biotechnology major Moderna on Friday sued rival Pfizer and BioNTech over alleged infringement of its messenger RNA (mRNA) ...
Read moreDetailsWashington: The US Food and Drug Administration (FDA) said that kid-sized doses of Pfizer-BioNTech's COVID-19 vaccine appear to be safe ...
Read moreDetailsWashington: Pfizer and its German partner BioNTech have said that preliminary clinical data showed their three-dose Covid-19 vaccine regimen was ...
Read moreDetailsChennai: Global pharma giant Pfizer, which developed the mRNA-based vaccine against Covid, on Wednesday announced setting up a global drug ...
Read moreDetailsGeneva: The World Health Organisation Friday made a strong recommendation for Pfizer's antiviral for mild and moderate Covid-19 patients at ...
Read moreDetailsGeneva: Thirty-five companies, from 12 countries including India, have signed an agreement to manufacture the generic version of Pfizer's oral ...
Read moreDetailsLondon: Doubts cast by several scientists and politicians alike over the efficacy of AstraZeneca Covid vaccine, developed in collaboration with the ...
Read moreDetails